Skip to main content
STELLA PHARMA CORPORATION logo

STELLA PHARMA CORPORATION — Investor Relations & Filings

Ticker · 4888 ISIN · JP3399680002 T Manufacturing
Open in API
Filings indexed 47 across all filing types
Latest filing 2023-02-13 Report Publication Anno…
Country JP Japan
Listing T 4888

About STELLA PHARMA CORPORATION

https://stella-pharma.co.jp/

Stella Pharma Corporation is a pharmaceutical company focused on the research and development of therapeutic drugs. The company specializes in boron compounds for Boron Neutron Capture Therapy (BNCT), a form of targeted radiation therapy for cancer. As a pioneer in the field, Stella Pharma developed the boron-based drug used in the first approved BNCT treatment for unresectable head and neck cancers. Its development pipeline is focused on expanding the application of BNCT to other difficult-to-treat malignancies, with clinical trials investigating its use for conditions such as cutaneous angiosarcoma.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan, specifically accompanying a Third Quarter Report (第３四半期報告書). While it references a quarterly report, the document itself is a formal regulatory filing confirming the accuracy of the financial statements. Given the specific nature of this regulatory confirmation filing, it falls under the general regulatory filings category.
2023-02-13 Japanese
四半期報告書－第16期第3四半期(2022/10/01－2022/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Stella Pharma Corporation, covering the third quarter of the 16th fiscal year (October 1, 2022, to December 31, 2022). It contains detailed financial statements, management analysis (MDA), and corporate information, which is characteristic of an Interim/Quarterly Report (IR). Q3 2023
2023-02-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act, which accompanies a Quarterly Report (Dai-ni shihanki hokokusho). While it references a quarterly report, the document itself is a formal regulatory filing confirming the accuracy of the financial statements for the second quarter. Given the specific nature of this regulatory confirmation filing, it falls under the general regulatory filings category.
2022-11-14 Japanese
四半期報告書－第16期第2四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kinki Finance Bureau in Japan. It contains detailed financial statements, including balance sheets and management analysis for the second quarter of the fiscal year ending 2023. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2022
2022-11-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act, which accompanies a Quarterly Report (Dai-ichi shihanki hokokusho). While it references the quarterly report, it is a formal regulatory filing confirming the accuracy of the financial statements for the first quarter. Given the specific nature of this confirmation document within the Japanese regulatory framework, it falls under the category of Regulatory Filings.
2022-08-10 Japanese
四半期報告書－第16期第1四半期(令和4年4月1日－令和4年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Stella Pharma Corporation, covering the period from April 1, 2022, to June 30, 2022. It contains detailed financial statements (balance sheet, income statement), notes to financial statements, and management analysis, which are characteristic of an interim/quarterly financial report. It is not an announcement of a report, but the report itself. Q1 2023
2022-08-10 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.